Navigation Links
Hologic to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
Date:1/30/2008

BEDFORD, Mass., Jan. 30 /PRNewswire-FirstCall/ -- Hologic, Inc. (Nasdaq: HOLX) today announced that Patrick Sullivan, Executive Chairman and Glenn Muir, Chief Financial Officer, will be presenting at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference being held February 5-7, 2008 at the Grand Hyatt Hotel in New York, NY.

Interested parties are invited to listen to a live audio webcast of Hologic's investor presentation on Tuesday, February 5, 2008 at 1:40 p.m. Eastern Time on the investor section of the Company's website at http://www.hologic.com/investor. An archive of the presentation will be available for replay following the conference.

About Hologic, Inc.

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic leads the industry in digital mammography systems and offers the most advanced technology for breast imaging and breast biopsy. Hologic's core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, osteoporosis assessment, preterm birth risk assessment, and mini C-arm for extremity imaging. For more information visit http://www.hologic.com.

Contact: Glenn P. Muir

Executive Vice President and CFO

Hologic, Inc.

(781) 999-73
'/>"/>

SOURCE Hologic, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Hologic, Inc. to Release First Quarter Fiscal 2008 Operating Results Thursday, January 31st Before Market Opens
2. Tengion to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
3. 3SBio Inc. to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
4. BioMarin to Present at the Merrill Lynch 2008 Global Healthcare Conference
5. Sagent Pharmaceuticals, Inc. to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
6. Thermo Fisher Scientific to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
7. Ardea Biosciences to Present Preclinical Data on Three HIV Non-Nucleoside Reverse Transcriptase Inhibitors During 15th Annual Conference on Retroviruses and Opportunistic Infections
8. Allos Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
9. Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference to Webcast Alexzas Corporate Presentation
10. Kendle to Present at the Wachovia 2008 Healthcare Conference
11. Phytomedics Inc. to Present at Wachovia 2008 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2013)... Angeles, CA (PRWEB) December 08, 2013 ... academia has benefited the Scientific Research and ... 61.3% of industry revenue, while other government funding ... by public sources, there has been a shift ... focus of industry research. “Historically, government money has ...
(Date:12/6/2013)... Fremont, CA (PRWEB) December 06, 2013 ... has set the standard for environmental monitoring with ... from Lighthouse Worldwide Solutions. The pharmacy’s latest improvement ... will bring new regulatory oversight to the compounding ... our top priorities, and we are constantly reinvesting ...
(Date:12/6/2013)... -- The promotion for An Involuntary Spy, http://www.amazon.com/Involuntary-Spy-GMO-Thriller-ebook/dp/B00GQPBLZ6 , ... was successful, ranking it a number 1 best seller ... first book of its kind, An Involuntary Spy breaks ... Eade . " There are spies, CIA, FBI and ... think. It also educates with a wealth of true information ...
(Date:12/6/2013)... Mass. , Dec. 6, 2013 The ... with its wholly-owned subsidiary, Anelixis Therapeutics, announced today that ... advance potential treatments for ALS , also known ... will explore a human monoclonal antibody that targets misfolded ... in familial and sporadic ALS, suggesting a generalized role ...
Breaking Biology Technology:Scientific Research and Development in the US Industry Market Research Report from IBISWorld Has Been Updated 2Scientific Research and Development in the US Industry Market Research Report from IBISWorld Has Been Updated 3JCB Laboratories Debuts High Tech Monitoring System That Will Further Enhance Patient Safety, Surpass Compounding Pharmacy Standards 2GMO Thriller, "An Involuntary Spy" a Number One Best Seller, Said to Break Open GMO Controversy 2ALS Therapy Development Institute and Neurimmune Partner to Advance Treatments for ALS 2ALS Therapy Development Institute and Neurimmune Partner to Advance Treatments for ALS 3
... Jennerex, Inc., a private clinical-stage biotherapeutics company focused ... oncolytic products for cancer, today announced that positive ... to treat patients with metastatic melanoma were published ... "This clinical trial in metastatic ...
... Computer files that allow us to watch videos, store pictures, ... but streams of "0" and "1" digital data, that is, ... ability to write, store, and retrieve digital information as efficiently ... in practice by writing information on a thin magnetic layer, ...
... Leading medical malpractice insurance company, Healthcare Providers Insurance Exchange ... New Jersey operations.  The company has opened a new ... continue servicing the medical community in New Jersey. HPIX ... New Jersey since 2005.   "This ...
Cached Biology Technology:Jennerex Reports Positive Mechanistic Proof-of-Concept Clinical Trial Results Using JX-594 to Treat Metastatic Melanoma 2Jennerex Reports Positive Mechanistic Proof-of-Concept Clinical Trial Results Using JX-594 to Treat Metastatic Melanoma 3Jennerex Reports Positive Mechanistic Proof-of-Concept Clinical Trial Results Using JX-594 to Treat Metastatic Melanoma 4The art of magnetic writing 2Medical Malpractice Insurance Company- Healthcare Providers Insurance Exchange (HPIX) has Expanded its Presence in New Jersey, Opens New Office 2
(Date:12/9/2013)... digging deep into the Earth,s surface collecting census data ... they,re finding is that, even miles deep and halfway ... quite similar. , The results, which were presented at ... these communities may be connected, said Matthew Schrenk, Michigan ... a scant idea about what microbes are present in ...
(Date:12/9/2013)... for the first UK multidisciplinary, integrated, science-led ... in Manchester, UK. , This conference will ... and help to build collaborations across research ... scientists and national facilities. , Duncan Eggar, ... RCUK Cross Council Bioenergy Strategic Coordination Group ...
(Date:12/9/2013)... crops rely on pollination by bees and other insect ... species is uncertain. Now researchers from North Carolina State ... the performance of pollinator species in order to determine ... for protection. , "Widespread concerns over the fate of ... efforts to understand which species are the most effective ...
Breaking Biology News(10 mins):Hard rock life 2Researchers develop system for assessing how effective species are at pollinating crops 2
... and Rongchao Jin have successfully used NMR to ... could advance the development and use of the ... approach offers a significant advantage over routine methods ... whether the nanoparticles exist in a both right-handed ...
... an important discovery about the mechanism controlling the body,s ... how proteins regulate appetite control and insulin secretion., This ... and Vascular Health at Warwick Medical School, found that ... a switch which is thrown depending on the composition ...
... widely cultivated for their beauty and medicinal properties. They ... 650-700 species ranging from Eurasia into North America, with ... was published in the open access journal ... for this group has revealed that three Mediterranean species ...
Cached Biology News:Carnegie Mellon researchers use NMR to determine whether gold nanoparticles exhibit 'handedness' 2Carnegie Mellon researchers use NMR to determine whether gold nanoparticles exhibit 'handedness' 3
... RNase A-type ribonucleases Product Description: ,QIAGEN RNase ... that binds noncovalently and inactivates a variety ... C). It does not interfere with RNase ... QIAGEN RNase Inhibitor inhibits greater than 90% ...
... Purity is >95%NEN Radiolabeled Ligands\n\nReceptor-related research has ... of new radiolabeled ligands selected to keep ... wide range of products and services for ... 400 state-of-the-art radioligands. If you do not ...
... The Polymerase gene from Thermus ... expressed in E. coli, then highly ... It is used in the amplification ... PCR. The quality of the Taq ...
Request Info...
Biology Products: